MedPath

The study of gut microbiota modulation by elobixibat in chronic constipatio

Not Applicable
Recruiting
Conditions
Chronic constipation
Registration Number
JPRN-UMIN000033259
Lead Sponsor
Yokohama City University School of Medicine Department of Gastroenterology and Hepatology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Patients who have severe complications (2) Patients who were administered elobixibat or antibiotics within 1 month (3) Patients who have history of elobixibat allergies (4) Patients who have bristol score 7 (5) Patients who have severe psychiatric disease (6) Patients who have current evidence of abuse of drugs or alcohol (7) Patients who or are going to take new medicines (8) Patients who or are going to be participating in other clinical studies (9) Patients who are judged as inadequately for study entry

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath